Pakistan Pharmaceuticals & Healthcare Q4 2018
Given systemic problems with intellectual property protection and the high prevalence of counterfeit medicines inparticular, Pakistan's pharmaceutical market will remain a low priority for innovative drugmakers, especially in light of the uncertainpolicy directions. In addition, the Pakistan-Tehreek-e-Insaf (PTI) political party is expected to upscale health coverage, increase thenumber of emergency units and generally implement programmes to improve health outcomes. Furthermore, the country's rapidlyexpanding population suggests strong development potential, though makers of innovative medicines are bound to remain varyof launching new innovative treatments in Pakistan.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook